1 November 2024 15:00 GMT Transparency DirectiveVoting rights and capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 October 2024 the issued share capital of AstraZeneca PLC with voting rights is 1,550,303,887 ordinary shares of US$0.25. No …
